NCT00911170 2017-12-29PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyAmgenPhase 3 Completed847 enrolled 21 charts
NCT00115206 2009-04-06Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyAmgenPhase 4 Completed
NCT00115414 2008-08-01Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)AmgenPhase 2 Completed